TrialJournal of gastroenterology2011

Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study.

Nobuo Hiwatashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.